Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takatoshi Sakurasawa

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Case Reports in Nephrology and Dialysis|July 24, 2023
Low-Density Lipoprotein Adsorption by Centrifugal Plasma Separation Can Shorten Treatment TimeAtsushi Ohkubo, Takatoshi Sakurasawa, Shotaro Naito
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|June 8, 2026
Centrifugation Selective Plasma Exchange: A Novel Hybrid Modality Combining Centrifugal Separation and Membrane-Based Plasma FractionationTakatoshi Sakurasawa, Atsushi Ohkubo, Soichiro Iimori, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|March 7, 2024
Investigation of treatment volume versus circulating blood volume during Rheocarna treatmentYuki Hoshikawa, Atsushi Ohkubo, Takatoshi Sakurasawa, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|April 22, 2021
Adjustment by hematocrit level in calculation of removal rate in therapeutic apheresisTakatoshi Sakurasawa, Atsushi Ohkubo, Yuki Hoshikawa, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|April 14, 2025
Rheocarna treatment for non-dialysis patientsAtsushi Ohkubo, Takatoshi Sakurasawa, Yuki Hoshikawa, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|August 17, 2023
Evaluation of the treatment volume and removal rate of Rheocarna: A novel adsorption-type blood purification device for patients with chronic limb-threatening ischemiaAtsushi Ohkubo, Takatoshi Sakurasawa, Yuki Hoshikawa, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|April 27, 2019
Removal Characteristics of Immunoadsorption with the Tryptophan-Immobilized Column Using Conventional and Selective Plasma Separators in the Treatment of Myasthenia GravisAtsushi Ohkubo, Tomokazu Okado, Takatoshi Sakurasawa, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Case Reports in Nephrology and Dialysis|July 24, 2023
Low-Density Lipoprotein Adsorption by Centrifugal Plasma Separation Can Shorten Treatment TimeAtsushi Ohkubo, Takatoshi Sakurasawa, Shotaro Naito
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|June 8, 2026
Centrifugation Selective Plasma Exchange: A Novel Hybrid Modality Combining Centrifugal Separation and Membrane-Based Plasma FractionationTakatoshi Sakurasawa, Atsushi Ohkubo, Soichiro Iimori, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|March 7, 2024
Investigation of treatment volume versus circulating blood volume during Rheocarna treatmentYuki Hoshikawa, Atsushi Ohkubo, Takatoshi Sakurasawa, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|April 22, 2021
Adjustment by hematocrit level in calculation of removal rate in therapeutic apheresisTakatoshi Sakurasawa, Atsushi Ohkubo, Yuki Hoshikawa, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|April 14, 2025
Rheocarna treatment for non-dialysis patientsAtsushi Ohkubo, Takatoshi Sakurasawa, Yuki Hoshikawa, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|August 17, 2023
Evaluation of the treatment volume and removal rate of Rheocarna: A novel adsorption-type blood purification device for patients with chronic limb-threatening ischemiaAtsushi Ohkubo, Takatoshi Sakurasawa, Yuki Hoshikawa, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|April 27, 2019
Removal Characteristics of Immunoadsorption with the Tryptophan-Immobilized Column Using Conventional and Selective Plasma Separators in the Treatment of Myasthenia GravisAtsushi Ohkubo, Tomokazu Okado, Takatoshi Sakurasawa, et al.
Pageof 1